Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Praga

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Clinical Kidney Journal|June 25, 2024
Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathyJoana Tavares, Fernando Caravaca-Fontán, Manuel Praga
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 28, 2014
[Persistent microhaematuria with negative or low proteinuria]Eduardo Gutiérrez, Juan A Moreno, Manuel Praga, et al.
Clinical Kidney Journal|November 29, 2021
Circulating active von Willebrand factor and immunoglobulin A nephropathy outcomesEduardo Gutiérrez, Hernández Eduardo, Enrique Morales, et al.
Nephron|November 4, 2020
Update on Lupus Nephritis: Looking for a New VisionEnrique Morales, Maria Galindo, Hernando Trujillo, et al.
Kidney International|April 24, 2021
The authors replyGema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Nephron|March 7, 2021
Which Patients with Obesity Are at Risk for Renal Disease?Justo Sandino, Leonella Luzardo, Enrique Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2026
Complement 3 Glomerulopathy (C3G) in Native and Posttransplant Kidneys: Pathophysiology, Prognosis, and TreatmentManuel Praga, Richard J Smith, Andrew S Bomback
Kidney International|March 22, 2021
The authors replyGema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Current Opinion in Critical Care|September 11, 2019
Acute kidney injury in interstitial nephritisFernando Caravaca-Fontán, Gema Fernández-Juárez, Manuel Praga
Clinical Kidney Journal|September 29, 2015
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?Jorge Rojas-Rivera, Gema Fernández-Juárez, Manuel Praga
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Clinical Kidney Journal|June 25, 2024
Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathyJoana Tavares, Fernando Caravaca-Fontán, Manuel Praga
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 28, 2014
[Persistent microhaematuria with negative or low proteinuria]Eduardo Gutiérrez, Juan A Moreno, Manuel Praga, et al.
Clinical Kidney Journal|November 29, 2021
Circulating active von Willebrand factor and immunoglobulin A nephropathy outcomesEduardo Gutiérrez, Hernández Eduardo, Enrique Morales, et al.
Nephron|November 4, 2020
Update on Lupus Nephritis: Looking for a New VisionEnrique Morales, Maria Galindo, Hernando Trujillo, et al.
Kidney International|April 24, 2021
The authors replyGema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Nephron|March 7, 2021
Which Patients with Obesity Are at Risk for Renal Disease?Justo Sandino, Leonella Luzardo, Enrique Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2026
Complement 3 Glomerulopathy (C3G) in Native and Posttransplant Kidneys: Pathophysiology, Prognosis, and TreatmentManuel Praga, Richard J Smith, Andrew S Bomback
Kidney International|March 22, 2021
The authors replyGema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Current Opinion in Critical Care|September 11, 2019
Acute kidney injury in interstitial nephritisFernando Caravaca-Fontán, Gema Fernández-Juárez, Manuel Praga
Clinical Kidney Journal|September 29, 2015
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?Jorge Rojas-Rivera, Gema Fernández-Juárez, Manuel Praga
Pageof 27